CITY NOW AT HIGH COVID RISK LEVEL: NYC Health Commissioner Dr. Ashwin Vasan released the following statement on May 17 on the city’s increased risk alert level: New York City has transitioned to a high COVID alert level, meaning now is the time to double down on protecting ourselves and each
Please enable Cookies and reload the page.
This process is automatic. Your browser will redirect to your requested content shortly.
Please allow up to 5 seconds…
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
AUSTIN, Texas, June 6, 2022 /PRNewswire/ -- CyberRatings.org, the non-profit entity dedicated to providing transparency on cybersecurity product efficacy, has completed an independent test of FortiGate-VM, Fortinet's virtual network firewall, as part of the first-ever Cloud Network Firewall ev
AUSTIN, Texas, June 6, 2022 /PRNewswire/ -- CyberRatings.org, the non-profit entity dedicated to providing transparency on cybersecurity product efficacy, has completed an independent test of FortiGate-VM, Fortinet's virtual network firewall, as part of the first-ever Cloud Network Firewall ev
Please stand by, while we are checking your browser...
Please enable Cookies and reload the page.
Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.
If you are on a personal connection, like at home, you can run an anti-virus sca
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page.
Expandable tables aren’t new. I remember crawling underneath tables as a child to help my mom insert additional l
Crenezumab failed to slow cognitive decline in the Alzheimer’s Prevention Initiative’s Colombian study, according to topline findings released June 15. Both primary endpoints were negative, although trends on the primaries and on multiple secondary and exploratory endpoints numericall
Crenezumab failed to slow cognitive decline in the Alzheimer’s Prevention Initiative’s Colombian study, according to topline findings released June 15. Both primary endpoints were negative, although trends on the primaries and on multiple secondary and exploratory endpoints numericall
by Astrobites | Jun 17, 2022 | Current Events | 0 comments
Welcome to the summer American Astronomical Society (AAS) meeting in Pasadena, CA, and online! Astrobites is attending the conference as usual, and we will report highlights from each day here. If you’d like to see